価格表
在庫・価格 : 2024年05月09日 08時58分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-Phospho-Akt (Thr308), Rabbit-Poly データシート |
AF3262 |
AFNアフィニティ バイオサイエンシズ Affinity Biosciences |
100 μl | ¥57,000 |
無 (未発注) |
追加 |
在庫・価格 : 2024年05月09日 08時58分 現在
使用文献
- No.: 1
-
文献情報:
Yang F et al. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 2017 03;485(1):54-61
Yang F et al
2017/01/01
-
備考:
-
参照:
- No.: 2
-
文献情報:
Ning C et al. Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer. Oncotarget 2017 Jul;8(27):44295-44311
Ning C et al
2017/01/01
-
備考:
-
参照:
- No.: 3
-
文献情報:
Logvinova DS et al. Transient interaction between the N-terminal extension of the essential light chain-1 and motor domain of the myosin head during the ATPase cycle. Biochem. Biophys. Res. Commun. 2018 01;495(1):163-167
Logvinova DS et al
2018/01/01
-
備考:
-
参照:
- No.: 4
-
文献情報:
Tian Y et al. Magnolol Alleviates Inflammatory Responses and Lipid Accumulation by AMP-Activated Protein Kinase-Dependent Peroxisome Proliferator-Activated Receptor α Activation. Front Immunol 2018;9:147
Tian Y et al
2018/01/01
-
備考:
-
参照:
- No.: 5
-
文献情報:
Su Y et al. Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo. Biochem. Pharmacol. 2018 02;148:13-26
Su Y et al
2018/01/01
-
備考:
-
参照:
- No.: 6
-
文献情報:
Zhou J et al. Cucurbitacin B suppresses proliferation of pancreatic cancer cells by ceRNA: Effect of miR-146b-5p and lncRNA-AFAP1-AS1. J Cell Physiol 2019 04;234(4):4655-4667
Zhou J et al
2019/01/01
-
備考:
-
参照:
- No.: 7
-
文献情報:
Li X et al. Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia. Haematologica 2019 11;104(11):2225-2240
Li X et al
2019/01/01
-
備考:
-
参照:
- No.: 8
-
文献情報:
Wu L et al. Morin reduces inflammatory responses and alleviates lipid accumulation in hepatocytes. J Cell Physiol 2019 11;234(11):19785-19798
Wu L et al
2019/01/01
-
備考:
-
参照:
- No.: 9
-
文献情報:
Shen B et al. Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/HO-1 and AMPK signalling pathways. J Cell Mol Med 2019 06;23(6):4063-4075
Shen B et al
2019/01/01
-
備考:
-
参照:
- No.: 10
-
文献情報:
Ma J et al. Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia. Clin Cancer Res 2019 11;25(22):6815-6826
Ma J et al
2019/01/01
-
備考:
-
参照:
- No.: 11
-
文献情報:
Gao B et al. Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3β pathway. Carcinogenesis 2020 Aug;41(8):1123-1133
Gao B et al
2020/01/01
-
備考:
-
参照:
- No.: 12
-
文献情報:
Chen R et al. FGFRL1 affects chemoresistance of small-cell lung cancer by modulating the PI3K/Akt pathway via ENO1. J Cell Mol Med 2020 02;24(3):2123-2134
Chen R et al
2020/01/01
-
備考:
-
参照:
- No.: 13
-
文献情報:
Li Y et al. Prediction of the mechanisms of Xiaoai Jiedu Recipe in the treatment of breast cancer: A comprehensive approach study with experimental validation. J Ethnopharmacol 2020 Apr;252:112603
Li Y et al
2020/01/01
-
備考:
-
参照:
- No.: 14
-
文献情報:
Chang W et al. MicroRNA-184 alleviates insulin resistance in cardiac myocytes and high fat diet-induced cardiac dysfunction in mice through the LPP3/DAG pathway. Mol Cell Endocrinol 2020 05;508:110793
Chang W et al
2020/01/01
-
備考:
-
参照:
- No.: 15
-
文献情報:
Shen B et al. Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signalling pathways. J Cell Mol Med 2020 05;24(9):5097-5108
Shen B et al
2020/01/01
-
備考:
-
参照:
- No.: 16
-
文献情報:
Hu C et al. CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action. J Cell Mol Med 2020 07;24(13):7239-7253
Hu C et al
2020/01/01
-
備考:
-
参照:
- No.: 17
-
文献情報:
Zhao Y et al. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling. Oncol Rep 2020 Sep;44(3):959-972
Zhao Y et al
2020/01/01
-
備考:
-
参照: